Effect of race on the glycaemic response to sitagliptin: Insights from the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).

Timothy M E DavisHillary MulderYuliya LokhnyginaPablo AschnerLee-Ming ChuangCarlos A Raffo GradoEberhard StandlEric D PetersonRury R Holmannull null

Published in: Diabetes, obesity & metabolism (2018)

The greatest initial reduction in HbA1c with sitagliptin in the TECOS population was in East Asians. No enhanced glycaemic effect was seen when sitagliptin was given with acarbose.

Keyphrases

type diabetes
clinical trial
phase iii
randomized controlled trial
phase ii
open label